Condensed cyclic compound and organic light-emitting device including the same

US9960365B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9960365-B2
Application numberUS-201514688434-A
CountryUS
Kind codeB2
Filing dateApr 16, 2015
Priority dateSep 26, 2014
Publication dateMay 1, 2018
Grant dateMay 1, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A condensed cyclic compound represented by Formula 1: wherein in Formula 1, groups L 1 and X 1 to X 16 are the same as described in the specification.

First claim

Opening claim text (preview).

What is claimed is: 1. A condensed cyclic compound represented by Formula 1: wherein in Formula 1, L 1 is selected from a phenylene group, a pyridinylene group, a pyrimidinylene group, and a triazinylene group; X 1 is N or CR 1 ; X 2 is N or CR 2 ; X 3 is N or CR 3 ; X 4 is N or CR 4 ; X 5 is N or CR 5 ; X 6 is N or CR 6 ; X 7 is N or CR 7 ; X 8 is N or CR 8 ; X 9 is N or CR 9 ; X 10 is N or CR 10 ; X 11 is N or CR 11 ; X 12 is N or CR 12 ; X 13 is N or CR 13 ; X 14 is N or CR 14 ; X 15 is N or CR 15 ; X 16 is N or CR 16 ; R 1 to R 16 are each independently selected from R ET , a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group; at least one selected from X 1 to X 16 is CR ET ; R ET is represented by any one of Formulae 2-1 to 2-8: wherein in Formulae 2-1 to 2-8, R 21 and R 22 are each independently selected from a substituted C 1 -C 60 alkyl group, a substituted C 1 -C 60 alkoxy group, a substituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted C 6 -C 60 aryloxy group, a substituted C 6 -C 60 arylthio group, a substituted unsubstituted C 1 -C 60 heteroaryl group, a substituted monovalent non-aromatic condensed polycyclic group, and a substituted monovalent non-aromatic condensed heteropolycyclic group; * indicates a binding site to a neighboring atom, and at least one of substituents of the substituted C 1 -C 60 alkyl group, substituted C 1 -C 60 alkoxy group, substituted C 3 -C 10 cycloalkyl group, substituted C 6 -C 60 aryl group, substituted C 6 -C 60 aryloxy group, substituted C 6 -C 60 arylthio group, substituted C 1 -C 60 heteroaryl group, substituted monovalent non-aromatic condensed polycyclic group, and substituted monovalent non-aromatic condensed heteropolycyclic group is selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, and a C 1 -C 60 alkoxy group; a C 1 -C 60 alkyl group, a C 1 -C 60 alkenyl group, a C 1 -C 60 alkynyl group, and a C 1 -C 60 alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, and —Si(Q 11 )(Q 12 )(Q 13 ); a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group; a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group, each substituted with at least one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 60 alkyl group, a C 1 -C 60 alkenyl group, a C 1 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, and —Si(Q 21 )(Q 22 )(Q 23 ); and —Si(Q 31 )(Q 32 )(Q 33 ), wherein Q 11 to Q 13 , Q 21 to Q 23 and Q 31 to Q 33 are each independently selected from a C 1 -C 60 alkyl group, a C 6 -C 60 aryl group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group. 2. The condensed cyclic compound of claim 1 , wherein L 1 is selected from Formulae 3-1 to 3-14; wherein in Formulae 3-1 to 3-14, * and *′ indicate each independently a binding site to a neighboring atom. 3. The condensed cyclic compound of claim 1 , wherein L 1 is selected from Formulae 3-2, 3-5, 3-6, 3-7, 3-11, 3-12, and 3-14: wherein in Formulae 3-2, 3-5, 3-6, 3-7, 3-11, 3-12, and 3-14, * and *′ indicate each independently a binding site to a neighboring atom. 4. The condensed cyclic compound of claim 1 , wherein X 1 is CR 1 X 2 is CR 2 ; X 3 is CR 3 ; X 4 is CR 4 ; X 5 is CR 5 ; X 6 is CR 6 ; X 7 is CR 7 ; X 8 is CR 8 ; X 9 is CR 9 ; X 10 is CR 10 ; X 11 is CR 11 ; X 12 is CR 12 ; X 13 is CR 13 ; X 14 is CR 14 ; X 15 is CR 15 ; and X 16 is CR 16 , or X 1 is N; X 2 is CR 2 ; X 3 is CR 3 ; X 4 is CR 4 ; X 5 is CR 5 ; X 6 is CR 6 ; X 7 is CR 7 ; X 8 is CR 8 ; X 9 is CR 9 ; X 10 is CR 10 ; X 11 is CR 11 ; X 12 is CR 12 ; X 13 is CR 13 ; X 14 is CR 14 ; X 15 is CR 15 ; and X 16 is CR 16 , or X 1 is CR 1 ; X 2 is N; X 3 is CR 3 ; X 4 is CR 4 ; X 5 is CR 5 ; X 6 is CR 6 ; X 7 is CR 7 ; X 8 is CR 8 ; X 9 is CR 9 ; X 10 is CR 10 ; X 11 is CR 11 ; X 12 is CR 12 ; X 13 is CR 13 ; X 14 is CR 14 ; X 15 is CR 15 ; and X 16 is CR 16 , or X 1

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9960365B2 cover?
A condensed cyclic compound represented by Formula 1: wherein in Formula 1, groups L 1 and X 1 to X 16 are the same as described in the specification.
Who is the assignee on this patent?
Samsung Electronics Co Ltd, Samsung Sdi Co Ltd
What technology area does this patent fall under?
Primary CPC classification H01L51/0072. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).